Basic information
- CAS
198481-33-3- Standard SMILES
CC(=O)O.Cc1c(-c2ccc(O)cc2)n(Cc2ccc(OCCN3CCCCCC3)cc2)c2ccc(O)cc12- InChIKey
OMZAMQFQZMUNTP-UHFFFAOYSA-N- Molecular formula
- C32H38N2O5
- Average molar mass
- 530.7 g/mol
- Monoisotopic mass
- 530.27807232
Overview
See also: Bazedoxifene (has active moiety); Bazedoxifene acetate; estrogens, conjugated (component of).
Names & identifiers
- Preferred name
- Bazedoxifene Acetate
- IUPAC
- acetic acid;1-[[4-[2-(azepan-1-yl)ethoxy]phenyl]methyl]-2-(4-hydroxyphenyl)-3-methylindol-5-ol
- English name
- Bazedoxifene acetate
- Molecular formula
- C32H38N2O5
- Molecular weight
- 530.67
Names & synonyms
Show more names
Database identifiers
- CAS
198481-33-3- PubChem CID
- 154256
- DTXSID
DTXSID3048657- ChEMBL
CHEMBL2106615- UNII
- J70472UD3D
- EC Number
- 638-804-4
Properties
Computed structural properties
- Topological polar surface area
- 95.2 Ų
- Hydrogen bond donors
- 3
- Hydrogen bond acceptors
- 6
- Rotatable bonds
- 7
- Heavy atoms
- 39
- Formal charge
- 0
- Complexity
- 654
Experimental & physicochemical properties
Human Drugs
FDA approved drugs -> Active ingredient
EMA approved medicines: Human medicine
FDA approved drugs -> Active ingredient
Physicochemical properties
- Melting point
- 174 · 174-178°
- storage temp.
- -20 °C · -20°C
- solubility
- 15 mg/mL, · DMSO: soluble15mg/mL, clear
- form
- powder
- color
- white to beige
- InChIKey
- DGEPGJZKMFNSDD-UHFFFAOYSA-N
- SMILES
- C(=O)(O)C.C(C1C=CC(OCCN2CCCCCC2)=CC=1)N1C2C=CC(O)=CC=2C(C)=C1C1C=CC(O)=CC=1
- FDA UNII
- 70472 UD3D · J70472UD3D
- UNSPSC Code
- 51111800 · 51111800
- NACRES
- 77 · NA.77
- Symbol(GHS)
- 7 · GHS07
- Signal word
- Warning
- Hazard statements
- 302 · H302-H315-H319
- Precautionary statements
- 261 · P261-P305+P351+P338
- WGK Germany
- 3 · 3
- Storage Class
- 11 · 11 - Combustible Solids
Safety & regulation
GHS classification
GHS Classification
Warning
H361 (93.8%): Suspected of damaging fertility or the unborn child [Warning Reproductive toxicity]
P203, P273, P280, P318, P391, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 32 reports by companies from 4 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Hazard information
Safety data
- wgk
- 3
- Signal word
- Warning
- Symbol(GHS)
- GHS07
- Storage Class
- 11 - Combustible Solids
- Hazard statements
- H302-H315-H319
- Precautionary statements
- P261-P305+P351+P338
Chemistry & industry
Pharmacology
MeSH Pharmacological Classification
A structurally diverse group of compounds distinguished from ESTROGENS by their ability to bind and activate ESTROGEN RECEPTORS but act as either an agonist or antagonist depending on the tissue type and hormonal milieu. They are classified as either first generation because they demonstrate estrogen agonist properties in the ENDOMETRIUM or second generation based on their patterns of tissue specificity. (Horm Res 1997;48:155-63)
Agents that inhibit BONE RESORPTION and/or favor BONE MINERALIZATION and BONE REGENERATION. They are used to heal BONE FRACTURES and to treat METABOLIC BONE DISEASES such as OSTEOPOROSIS.
Applications
UsesBazedoxifene acetate has been used to study its efficacy in inhibiting the interleukin-6 (IL-6)/IL-6R/glycoprotein 130 pathway and its effects on medulloblastoma cells.
UsesBazedoxifene Acetate is a nonsteroidal selective estrogen receptor modulator (SERM). Bazedoxifene Acetate is used as an antiosteoporotic.
Suppliers101 total
Related reactions
Compound notes
Loading…